BACKGROUND: Minimization of blood loss during pancreatoduodenectomy requires careful surgical technique and specific preventative measures. Therefore, red blood cell (RBC) transfusions and operative time are potential surgical quality indicators. The aim of the present study was to compare peri-operative RBC transfusion and operative time with 30-day morbidity/mortality after pancreatoduodenectomy. METHODS: All pancreatoduodenectomies (2005 to 2008) were identified using the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP). RBC transfusions and operative time were correlated with 30-day morbidity/mortality. RESULTS: Pancreatoduodenectomy was completed in 4817 patients. RBC transfusions were given to 1559 (32%) patients (1-35 units). Overall morbidity and mortality rates were 37% and 3.0%, respectively. Overall 30-day morbidity increased in a stepwise manner with the number of RBC transfusions (R = 0.69, P < 0.01). Although RBC transfusions and operative times were not statistically linked (P = 0.87), longer operative times were linearly associated with increased 30-day morbidity (R = 0.79, P < 0.001) and mortality (R = 0.65, P < 0.01). Patients who were not transfused also displayed less morbidity (33%) and mortality (1.9%) (P < 0.05). DISCUSSION: Peri-operative RBC transfusion after pancreatoduodenectomy is linearly associated with 30-day morbidity. Longer operative time also correlates with increased morbidity and mortality. Therefore, blood transfusions and prolonged operative time should be considered quality indicators for pancreatoduodenectomy.
BACKGROUND: Minimization of blood loss during pancreatoduodenectomy requires careful surgical technique and specific preventative measures. Therefore, red blood cell (RBC) transfusions and operative time are potential surgical quality indicators. The aim of the present study was to compare peri-operative RBC transfusion and operative time with 30-day morbidity/mortality after pancreatoduodenectomy. METHODS: All pancreatoduodenectomies (2005 to 2008) were identified using the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP). RBC transfusions and operative time were correlated with 30-day morbidity/mortality. RESULTS: Pancreatoduodenectomy was completed in 4817 patients. RBC transfusions were given to 1559 (32%) patients (1-35 units). Overall morbidity and mortality rates were 37% and 3.0%, respectively. Overall 30-day morbidity increased in a stepwise manner with the number of RBC transfusions (R = 0.69, P < 0.01). Although RBC transfusions and operative times were not statistically linked (P = 0.87), longer operative times were linearly associated with increased 30-day morbidity (R = 0.79, P < 0.001) and mortality (R = 0.65, P < 0.01). Patients who were not transfused also displayed less morbidity (33%) and mortality (1.9%) (P < 0.05). DISCUSSION: Peri-operative RBC transfusion after pancreatoduodenectomy is linearly associated with 30-day morbidity. Longer operative time also correlates with increased morbidity and mortality. Therefore, blood transfusions and prolonged operative time should be considered quality indicators for pancreatoduodenectomy.
Authors: John D Birkmeyer; David M Shahian; Justin B Dimick; Samuel R G Finlayson; David R Flum; Clifford Y Ko; Bruce Lee Hall Journal: J Am Coll Surg Date: 2008-09-19 Impact factor: 6.113
Authors: Anna R Gagliardi; Michael Fung Kee Fung; Bernard Langer; Hartley Stern; Adalsteinn D Brown Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Purvi Y Parikh; Henry A Pitt; Molly Kilbane; Thomas J Howard; Attila Nakeeb; C Max Schmidt; Keith D Lillemoe; Nicholas J Zyromski Journal: J Am Coll Surg Date: 2009-10-17 Impact factor: 6.113
Authors: Shukri F Khuri; William G Henderson; Jennifer Daley; Olga Jonasson; R Scott Jones; Darrell A Campbell; Aaron S Fink; Robert M Mentzer; Janet E Steeger Journal: J Am Coll Surg Date: 2007-06 Impact factor: 6.113
Authors: D Robert Siemens; Melanie T Jaeger; Xuejiao Wei; Francisco Vera-Badillo; Christopher M Booth Journal: World J Urol Date: 2017-02-17 Impact factor: 4.226
Authors: Patrick B Schwartz; Alexandra M Roch; Jane S Han; Alex V Vaicius; William P Lancaster; E Molly Kilbane; Michael G House; Nicholas J Zyromski; C Max Schmidt; Atilla Nakeeb; Eugene P Ceppa Journal: Surg Endosc Date: 2017-06-29 Impact factor: 4.584
Authors: Alban Zarzavadjian Le Bian; Nicolas Tabchouri; Mostefa Bennamoun; Christophe Louvet; Candice Tubbax; Anthony Sarran; Marine Lefevre; Marc Beaussier; Frédéric Pamoukdjian; Philippe Wind; Brice Gayet; David Fuks Journal: Surg Endosc Date: 2019-01-22 Impact factor: 4.584
Authors: Donald J Lucas; Katherine I Schexneider; Matthew Weiss; Christopher L Wolfgang; Steven M Frank; Kenzo Hirose; Nita Ahuja; Martin Makary; John L Cameron; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2013-12-10 Impact factor: 3.452
Authors: Russell Lewis; Jeffrey A Drebin; Mark P Callery; Douglas Fraker; Tara S Kent; Jenna Gates; Charles M Vollmer Journal: HPB (Oxford) Date: 2012-09-24 Impact factor: 3.647